Instalab
logoInstalab

Gluteomorphin IgG

Blood Test
Get an early, exploratory read on how your immune system responds to a gluten breakdown product.
4.9 (4,899 reviews)
Tested by Vibrant America
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Gluteomorphin IgG test?

This test is most useful if any of these apply to you.

Told Your Gut Tests Look Normal
Your celiac and allergy tests came back clear, but you still suspect wheat and want another angle to explore.
Thinking About Going Gluten-Free
See where your gluten-related antibodies sit before you change your diet, so you have a baseline to compare against later.
Chasing Unexplained Digestive Symptoms
Bloating or fatigue with no clear cause, and you want to see how your immune system responds to a gluten breakdown product.
Curious About Food and Your Immune System
Feeling well but interested in exploratory markers of how your body meets what you eat, alongside more established tests.

About Gluteomorphin IgG

If you have cut back on wheat and felt better, or you suspect gluten is behind bloating, fatigue, or brain fog, you have probably wondered whether a blood test could settle it. This is one of the tests marketed for exactly that hope.

Here is the honest starting point. A result here tells you your immune system has met a gluten breakdown product, not that gluten is harming you. Knowing that difference is the whole point of reading further.

What Gluteomorphin Actually Is

Gluteomorphin IgG (also called gliadorphin IgG) measures one specific antibody. When your body digests the gluten in wheat, it releases short protein fragments. One of these fragments behaves a little like a mild opioid, which is where the name comes from. Your immune system can make IgG (immunoglobulin G, a general-purpose antibody your body builds up after repeated contact with a substance) against that fragment, and this test measures how much of it is circulating.

One thing to be clear about upfront: "gluteomorphin" is a term used mainly by commercial and alternative-medicine labs, not in mainstream medical literature. The peer-reviewed evidence discussed here comes from studies of native anti-gliadin antibodies, a related but distinct family of gluten-fragment tests. That is the closest validated science we have, and it is the lens through which any result should be read.

Producing IgG against something you eat is, on its own, a normal immune response. These food-related antibodies are common and largely reflect exposure rather than disease. Anti-gliadin IgG, for example, is found in roughly 10 to 15 out of 100 people in the general population who do not have celiac disease. That single fact reframes how you should read your number.

What a Result Actually Reflects

A higher level signals that your immune system is recognizing and responding to this gluten fragment, usually because you regularly eat wheat. A lower level usually means less exposure or less immune recognition. This is not a good-number, bad-number test.

It is tempting to read a positive result as proof that gluten is damaging you, but the evidence does not support that leap. Antibodies against gluten-derived molecules show up in people with celiac disease, in people with irritable bowel syndrome, in people with autoimmune conditions, and in perfectly healthy people. In one study of adults being evaluated for gluten sensitivity, antibodies against gliadin (a gluten protein, related to but not the same as gluteomorphin) were found in about 25 out of 100 people, and they also appear in healthy controls. The same result can mean very different things in different bodies, which is why a positive is not proof of harm and a negative does not clear gluten as a trigger.

How This Differs From Celiac Testing

Celiac disease has a well-validated blood workup, and this is not part of it. Guidelines point to tissue transglutaminase IgA plus a total IgA measurement as the first-line screen. Gluteomorphin IgG belongs to the older family of native gluten-fragment antibodies, and that family has historically been the weakest performer for detecting actual disease.

What Was TestedHow It Was ComparedWhat They Found
Native gliadin IgG (the antibody family this test resembles)Ability to detect biopsy-confirmed celiac diseaseCaught roughly 4 to 6 out of 10 true cases in most studies, and the weakest of these three
Deamidated gliadin peptide IgG (a newer, refined version)Same comparison, same patientsCaught a clear majority of true cases, better than native gliadin IgG
Tissue transglutaminase IgA (the standard screen)Same comparison, same patientsCaught more than 9 out of 10 true cases, the strongest performer

Reported sensitivities vary widely from study to study, so treat these as a ranking rather than fixed figures: across published reviews, native gliadin IgG has ranged anywhere from about 25 to 90 percent, while tissue transglutaminase IgA consistently sits above 95 percent. What this means for you: if celiac disease is a genuine question, the validated tissue transglutaminase test is the one to order, and you need to be eating gluten when you take it. A native gluten-fragment antibody is not a substitute.

The Gluten Sensitivity Question

Many people order this test hoping to confirm non-celiac gluten sensitivity, a real cluster of symptoms triggered by wheat in people who do not have celiac disease or a wheat allergy. No blood marker, including this one, has been validated to diagnose that condition. The diagnosis still rests on symptoms and a supervised removal and reintroduction of gluten, ideally guided by a clinician.

Brain Fog and Cognition

A popular belief holds that gluten antibodies signal hidden effects on the brain. In people without celiac disease who happened to carry gliadin antibodies (again, related to but not identical to gluteomorphin), a case-control study of adults aged 50 to 70 found no differences in cognitive testing, quality of life, or brain MRI compared with people who did not carry them. Incidental positivity was not linked to any measurable neuropsychological problem.

Why One Reading Tells You Little

Because this antibody largely tracks gluten exposure, a single number is a snapshot of your recent diet and immune activity, not a fixed trait. The useful signal, if there is one, comes from watching change over time rather than from any one value.

A sensible approach: get a baseline while eating your normal diet, then retest after a deliberate dietary change, roughly 3 to 6 months later, and see whether the number and your symptoms move together. One caveat on tracking. The evidence that gluten antibodies fall when you stop eating gluten comes from related celiac markers such as tissue transglutaminase IgA and deamidated gliadin peptide IgG, which drop measurably within months of starting a gluten-free diet and typically normalize over 3 to 12 months, not from studies of gluteomorphin IgG specifically.

Making Sense of an Unexpected Result

A high result with digestive or systemic symptoms is a prompt to reach for the tests that have validated meaning. Order tissue transglutaminase IgA with total IgA while you are still eating gluten, because going gluten-free first can mask celiac disease on those tests. If wheat triggers rapid hives or breathing trouble, wheat-specific IgE and an allergist address the question of true allergy, which is a different immune pathway entirely.

Combinations are what matter. A high gluteomorphin IgG alongside a positive tissue transglutaminase result points toward a celiac workup with a gastroenterologist. A high gluteomorphin IgG on its own, in someone who eats wheat and feels well, usually reflects exposure and needs nothing beyond that context. You should never finish this test thinking a single number has made a diagnosis for you.

When Results Can Be Misleading

  • Recent gluten avoidance: if you have already cut gluten, both this antibody and the validated celiac tests can drop, producing a falsely reassuring result. This is the single most common trap, and it is why celiac testing should happen before you change your diet.
  • No standardized cutoff: there is no agreed threshold that defines a normal versus abnormal level for this marker, so a lab flagging you as high is using its own reference, not a validated clinical line.
  • Assay variability between labs: IgG food-antibody tests are not standardized, so the same blood sample can produce different numbers at different labs. Compare trends within one lab rather than across them.
  • Reading exposure as injury: a rising number in someone eating more wheat reflects contact, not damage, and does not by itself indicate any disease process.

What Moves This Biomarker

Evidence-backed interventions that affect your Gluteomorphin IgG level

↑ Increase
Eat wheat and other gluten-containing grains regularly
Eating gluten gives your immune system the exposure it needs to produce and sustain these antibodies, so ongoing intake tends to keep the level higher, and removing gluten tends to lower it. The number reflects exposure, not injury, so a rise or fall here does not by itself mean gluten is helping or harming you. Direct trials on gluteomorphin IgG are lacking; this pattern is inferred from related celiac antibodies such as tissue transglutaminase IgA and deamidated gliadin peptide IgG, which drop measurably within months of starting a gluten-free diet and typically normalize over 3 to 12 months.
DietModerate Evidence

Frequently Asked Questions

Panels containing Gluteomorphin IgG

Gluteomorphin IgG is included in these pre-built panels.

References

16 studies
  1. Litwin a, Le Thi TG, El-lababidi N, Kindermann a, Pancheva RZ, Gerasimidis K, Goncalves C, Crespo Escobar P, Niseteo T, Ikrath K, Koletzko SJournal of Pediatric Gastroenterology and Nutrition2025
  2. Catassi G, Catassi CExpert Review of Molecular Diagnostics2025
  3. Husby S, Koletzko S, Korponay-szabo I, Kurppa K, Mearin M, Ribes-koninckx C, Shamir R, Troncone R, Auricchio R, Castillejo G, Christensen R, Dolinsek J, Gillett P, Hrobjartsson a, Koltai T, Maki M, Nielsen S, Popp a, Werkstetter K, Wessels MJournal of Pediatric Gastroenterology and Nutrition2020
  4. Rashtak S, Ettore MW, Homburger H, Murray JClinical Gastroenterology and Hepatology2008
  5. Hopper a, Hadjivassiliou M, Hurlstone DP, Lobo a, Mcalindon M, Egner W, Wild G, Sanders DClinical Gastroenterology and Hepatology2008